Medicare Enrolled

Dr. Linda Wang, M.D.

Endocrinology · Long Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2840 LONG BEACH BLVD, Long Beach, CA 90806
5629888787
In practice since 2007 (18 years)
NPI: 1073794368 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wang

Dr. Linda Wang is an endocrinology specialist in Long Beach, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Wang performed 920 Medicare services across 386 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wang received a total of $10,141 from 40 pharmaceutical and/or device companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 44% volume in CA $10,141 industry payments

Medicare Practice Summary

Medicare Utilization ↗
920
Medicare services
Top 44% in CA for endocrinology
386
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
394 $108 $250
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
239 $76 $150
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
227 $29 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
31 $137 $350
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
17 $154 $300
New patient office visit, complex (60-74 min) 12 $188 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,141
Total received (2018-2024)
Avg $1,449/year across 7 years
Top 19% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
559
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,141 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$66
2023
$1,397
2022
$1,383
2021
$1,072
2020
$1,220
2019
$2,416
2018
$2,587

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$23
Lilly USA, LLC
$22
Radius Health, Inc.
$21
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,036
MannKind Corporation
$836
AstraZeneca Pharmaceuticals LP
$745
Insulet Corporation
$722
Boehringer Ingelheim Pharmaceuticals, Inc.
$589
Novo Nordisk Inc
$570
SANOFI-AVENTIS U.S. LLC
$538
Radius Health, Inc.
$507
Dexcom, Inc.
$495
Mannkind Corporation
$467
Valeritas, Inc.
$441
Abbott Laboratories
$385
Amgen Inc.
$366
Amarin Pharma Inc.
$316
Janssen Pharmaceuticals, Inc
$282
Corcept Therapeutics
$252
Horizon Therapeutics plc
$246
Merck Sharp & Dohme Corporation
$172
AbbVie, Inc.
$170
DEXCOM, INC.
$136
Tandem Diabetes Care, Inc.
$120
AbbVie Inc.
$108
Shire North American Group Inc
$101
Zealand Pharma US, Inc.
$58
CeQur Corporation
$53
VistaPharm, Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$47
Bigfoot Biomedical Inc
$46
Becton, Dickinson and Company
$42
Embecta Corp.
$30
Ascensia Diabetes Care US Inc.
$30
Merck Sharp & Dohme LLC
$24
Xeris Pharmaceuticals, Inc.
$24
Medtronic MiniMed, Inc.
$23
Ascensia Diabetes Care Us Inc.
$22
LifeScan, Inc.
$22
Kyowa Kirin, Inc.
$20
Medtronic, Inc.
$17
ABBVIE INC.
$16
Terumo Medical Corporation
$16
Top 3 companies account for 25.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ANGIO-SEAL · Androgel · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · CeQur Simplicity · Contour Next · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · HUMALOG · HUMULIN · INVOKANA · JANUVIA · JARDIANCE · Korlym · MOUNJARO · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · Ozempic · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Thyquidity · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XARELTO · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Long Beach?
Compare endocrinologists in the Long Beach area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
284
Per 100K population
2.9
County median income
$87,760
Nearest hospital
MEMORIALCARE LONG BEACH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wang is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wang experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wang performed 394 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $10,141 from 40 companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other endocrinologists in Long Beach?
Dr. Wang's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →